Patricia Russo Santangelo
About Patricia Russo Santangelo
Patricia Russo Santangelo serves as the Director of Data Management at Prothena Corporation plc, bringing over 25 years of experience in the pharmaceutical and biotech industries, particularly in oncology and early drug development.
Current Role at Prothena Corporation
Patricia Russo Santangelo serves as the Director of Data Management at Prothena Corporation plc. She has held this position since 2022, contributing her expertise in data management within the pharmaceutical and biotech sectors. Her role involves overseeing data management processes and ensuring compliance with industry standards in Summit, NJ.
Previous Experience in Data Management
Prior to her current role, Patricia held several significant positions in data management. She worked at Cmed as a Project Trial Leader from 2004 to 2007. Following that, she spent 12 years at Celgene as Associate Director from 2007 to 2019. Most recently, she served as Associate Director of Data Management at Bristol Myers Squibb from 2019 to 2022 in the Greater New York City Area.
Educational Background
Patricia Russo Santangelo studied at Binghamton University from 1979 to 1983. She furthered her education at Stevens Institute of Technology, where she earned an MBA in Information Systems. Additionally, she attended Hunter College, enhancing her academic credentials.
Expertise in Clinical Data Management
With over 25 years of experience in the pharmaceutical, biotech, and medical device industries, Patricia specializes in clinical data management systems. She has managed both paper and electronic data capture (EDC) trials across all phases of clinical research. Her expertise includes systems such as RAVE, InForm, Oracle, Timaeus, Inquire, and SAS.
Focus on Oncology and Neurodegenerative Diseases
Patricia has a strong focus on oncology and early drug development throughout her career. In addition to her work in oncology, she has expanded her portfolio to include Alzheimer's Disease and other neurodegenerative diseases, reflecting her commitment to addressing complex health challenges.